Seroquel Paragraph IV Certification Filed
This article was originally published in The Pink Sheet Daily
Executive Summary
The first ANDA with a Paragraph IV certification for AstraZeneca's Seroquel (quetiapine) was filed Aug. 12, according to FDA's Oct. 4 updated list of filings
You may also be interested in...
Seroquel Sustained-Release Could Avert Sunset On Patent Exclusivity, AstraZeneca Says
Company will file an NDA for the SR formulation of quetiapine for schizophrenia in July.
Cancer-Genomics Firm Quanticel Debuts With Close Ties To Celgene, And An Exit In Mind
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.